BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1911 related articles for article (PubMed ID: 27255828)

  • 1. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic study of serum, urine and bronchoalveolar lavage fluid based on gas chromatography mass spectrometry to delve into the pathology of lung cancer.
    Callejón-Leblic B; García-Barrera T; Pereira-Vega A; Gómez-Ariza JL
    J Pharm Biomed Anal; 2019 Jan; 163():122-129. PubMed ID: 30292984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic analysis of lung epithelial secretions in rats: an investigation of bronchoalveolar lavage fluid by GC-MS and FT-IR.
    Qamar W; Ahamad SR; Ali R; Khan MR; Al-Ghadeer AR
    Exp Lung Res; 2014 Nov; 40(9):460-6. PubMed ID: 25153043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profile perturbations of serum, lung, bronchoalveolar lavage fluid, spleen and feces in LPS-induced acute lung injury rats based on HPLC-ESI-QTOF-MS.
    Wang T; Lin S; Liu R; Li H; Liu Z; Zhang X; Xu H; Li Q; Bi K
    Anal Bioanal Chem; 2020 Feb; 412(5):1215-1234. PubMed ID: 31940090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
    Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
    Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).
    Pastor MD; Nogal A; Molina-Pinelo S; Quintanal-Villalonga Á; Meléndez R; Ferrer I; Romero-Romero B; De Miguel MJ; López-Campos JL; Corral J; García-Carboner R; Carnero A; Paz-Ares L
    J Thorac Oncol; 2016 Dec; 11(12):2183-2192. PubMed ID: 27524264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
    Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
    Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolomic detection of lung cancer biomarkers in sputum.
    Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
    Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
    Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer.
    Biaoxue R; Xiguang C; Hua L; Tian F; Wenlong G
    Int J Biol Markers; 2017 Mar; 32(1):e132-e140. PubMed ID: 28009433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry.
    Chen Y; Ma Z; Li A; Li H; Wang B; Zhong J; Min L; Dai L
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):705-18. PubMed ID: 25293627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
    Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung Cancers.
    Sim SY; Choi YR; Lee JH; Lim JM; Lee SE; Kim KP; Kim JY; Lee SH; Kim MS
    Proteomics Clin Appl; 2019 Sep; 13(5):e1900028. PubMed ID: 31119868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS.
    Chen J; Hou H; Chen H; Luo Y; Zhang L; Zhang Y; Liu H; Zhang F; Liu Y; Wang A; Hu Q
    J Pharm Biomed Anal; 2019 Apr; 167():83-89. PubMed ID: 30759408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.
    Evans CR; Karnovsky A; Kovach MA; Standiford TJ; Burant CF; Stringer KA
    J Proteome Res; 2014 Feb; 13(2):640-9. PubMed ID: 24289193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 96.